Deep Tech Startups

Bioqore builds Voyager, an AI-powered closed-loop bioprocess intelligence platform that combines predictive modeling with micro-scale laboratory experiments to recommend and validate optimal process conditions for producing preclinical- and clinic-ready therapeutic candidates. It serves biotech and pharma teams working on bioprocess development, scale-up, and biomanufacturing.

3 investors

BioScout provides autonomous, solar-powered air sampling devices that detect and identify airborne fungal spores, combining live spore counts with weather data to give growers, agronomists, and agrochemical distributors disease-risk intelligence for fungicide spray timing. Its system uses patented sensor technology and light microscopy to map crop disease risk and reduce unnecessary fungicide applications.

3 investors

BioSqueeze develops well integrity solutions for the oil and gas industry, using biomineralization technology to seal cement gaps and leaks in wells. The company offers multiple sealing products (MicroSeal, MacroSeal, NanoSeal) and diagnostic services for well remediation and decommissioning.

3 investors

Biota develops rapid PFAS testing technologies, including field-compatible test kits and lab sample-prep products, that deliver results in about 15 minutes instead of weeks. It serves PFAS treatment companies and testing labs to speed up field monitoring and regulated confirmatory analysis for water cleanup.

3 investors

Bioventus develops and markets medical devices for active healing, including pain management, restorative therapies, and surgical solutions that aim to enhance the body's natural healing processes and reduce the need for invasive procedures. The company serves healthcare providers and patients seeking clinically effective, cost-efficient alternatives to traditional treatments.

3 investors

bitHuman turns photos into real-time, lip-synced video avatars and AI characters with voice, running fully on-device across hardware from Raspberry Pi to iPhone to NVIDIA GPUs. It offers Python and Swift SDKs, a REST API, and a no-code dashboard for developers building talking avatars, illustrated multimedia books, and privacy-sensitive, self-hosted or air-gapped deployments.

3 investors

Bitsensing develops radar technology solutions for automotive safety, smart home systems, industrial automation, and urban infrastructure management using advanced signal processing and AI-driven insights. The company serves clients across automotive, smart city, and industrial sectors globally.

3 investors

Blaize develops edge AI computing platforms and software tools that enable efficient deployment of artificial intelligence models on edge devices with reduced power consumption and latency compared to traditional GPU/CPU solutions.

3 investors

Blu Wireless develops millimeter wave radio networking technology for wireless communications. The company specializes in mmWave networking solutions.

3 investors

Blynt builds customized speech recognition engines that outperform off-the-shelf models on domain-specific real-world audio, delivered through a workflow for picking base models, composing pre-trained adapters, injecting domain terms and context, and benchmarking word error rate and latency before deployment. It serves product teams needing tailored speech understanding for use cases such as clinical dictation, voice agents, and voice control.

3 investors

BMI OrganBank develops organ perfusion and preservation systems to improve transplantation outcomes and extend organ viability outside the body. The company serves transplant clinicians and researchers working to reduce organ transplant waitlists and advance regenerative medicine.

3 investors

Bolden Therapeutics is a biotechnology company developing therapeutics that promote neurogenesis—the formation of new brain cells—to treat neurological and central nervous system diseases such as Alzheimer's. Its lead approach uses exon-skipping antisense oligonucleotides, with multiple therapeutic modalities in preclinical development.

3 investors

Boltz develops generative AI models for biomolecular design and drug discovery, used by researchers across pharmaceutical, biotech, agricultural, and academic sectors. The company offers frontier foundation models for protein and small-molecule design through an API with enterprise deployment options.

3 investors

Bota offers engineered protein solutions through strain optimization and screening, leveraging proprietary datasets to increase protein yield while reducing production costs for industrial biotech applications.

3 investors

Botalys develops a platform for creating rare botanical ingredients tailored for nutraceutical and cosmetic applications through structured co-development partnerships with industry leaders. The platform guides partners through plant selection, validation, sourcing, cultivation, and industrial-scale production of specialized botanical ingredients.

3 investors

Braintree is developing an AI technology based on dynamic, adaptive relationship structures rather than large-scale predictive models, aimed at reasoning, explainability, and efficiency. Its long-term vision, called "Sunny," is an expression of what it terms Symbolic Digital Consciousness—intelligence that can learn, reason, adapt, and act.

3 investors

Breakout is a venture capital firm that has invested for over a decade in science-driven technology companies across biotech, tech-bio, deep tech, and hard tech. It partners with founders scaling scientific innovation and connects them to corporates, strategic partners, and next-stage investors.

3 investors

BreezeBio develops a programmable delivery platform called NanoGalaxy for targeted delivery of genetic medicines to specific cells and tissues. The platform addresses the challenge of enabling genetic payloads to reach their target sites in the body to control biological processes.

3 investors

Bright Minds Biosciences develops selective serotonin receptor agonists (5-HT2A and 5-HT2C) without 5-HT2B activity, built on a proprietary chemistry platform. The company targets central nervous system and brain disorders through serotonin regulation.

3 investors

BrightSpec develops molecular rotational resonance (MRR) spectroscopy instruments and software that identify and quantify gas-phase molecules from complex mixtures without front-end separation. Its analytical platforms serve the pharmaceutical, chemical, and consumer goods industries for tasks such as structure validation, residual analysis, and raw material characterization.

3 investors

Brinker provides a SaaS platform that uses artificial intelligence and machine learning to detect, analyze, and counter security threats including misinformation narratives and attacks at scale across multiple sources and languages. The platform is designed for organizations needing rapid threat severity assessment and proactive response capabilities aligned with regulatory requirements.

3 investors

ByBug is a biotech startup that uses genetic engineering and black soldier fly (Hermetia illucens) biomanufacturing to produce oral biological feed additives that prevent diseases such as Caligus in salmon and White Spot Syndrome Virus in shrimp. Its functional additives are mixed into existing animal feed for aquaculture producers, with a stated focus on the Chilean salmon industry and the global shrimp market.

3 investors

Caelus is a chip design company that develops high-performance ADC/DAC integrated circuits, including high-precision SAR ADCs and high-speed ADCs, using its own patented technology. Its products serve industries such as industrial automation, energy, instrumentation and measurement, data acquisition, communications, and medical imaging.

3 investors

Cajal Therapeutics develops novel therapies through translating scientific advances into treatments for patients. The company is led by a team of experienced scientists and operators focused on drug discovery and development.

3 investors